|
EIF3E expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.470400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.847800E-01 |
| Normal-vs-Stage2 |
2.226000E-01 |
| Normal-vs-Stage3 |
4.258200E-01 |
| Normal-vs-Stage4 |
4.063000E-01 |
| Stage1-vs-Stage2 |
7.935900E-02 |
| Stage1-vs-Stage3 |
1.501170E-01 |
| Stage1-vs-Stage4 |
4.729400E-01 |
| Stage2-vs-Stage3 |
5.148800E-01 |
| Stage2-vs-Stage4 |
6.207800E-02 |
| Stage3-vs-Stage4 |
9.671500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.292000E-01 |
| Normal-vs-AfricanAmerican |
7.132400E-01 |
| Normal-vs-Asian |
3.596400E-01 |
| Caucasian-vs-AfricanAmerican |
6.440800E-01 |
| Caucasian-vs-Asian |
2.508200E-01 |
| AfricanAmerican-vs-Asian |
7.334000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.916800E-01 |
| Normal-vs-Female |
9.471600E-01 |
| Male-vs-Female |
4.964800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.074800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.020400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.585000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.695800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.933600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.204400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.856170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.891000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.641800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.955800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.056200E-01 |
| Classical-VS-Follicular |
4.064200E-02 |
| Classical-VS-Other |
2.486600E-01 |
| Classical-VS-Normal |
5.785400E-01 |
| Tall-VS-Follicular |
1.121380E-01 |
| Tall-VS-Other |
3.761600E-01 |
| Tall-VS-Normal |
5.620400E-01 |
| Follicular-VS-Other |
1.410230E-01 |
| Follicular-VS-Normal |
2.422800E-01 |
| Other-VS-Normal |
2.062800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.059800E-01 |
| Normal-vs-N1 |
7.867800E-01 |
| N0-vs-N1 |
7.145200E-01 |
|
|
